Related Experiment Videos
Contrast sensitivity function and pituitary adenoma: a study of 40 cases
M Grochowicki1, A Vighetto, S Berquet
1Hôpital Neurologique et Neuro-Chirurgical Pierre Wertheimer, Lyon, France.
The British Journal of Ophthalmology
|June 1, 1990
Summary
Pituitary adenoma can compress the visual pathway. The contrast sensitivity function is a potential indicator of this compression, though it requires further validation due to limited specificity.
Area of Science:
- Ophthalmology
- Neuroscience
- Endocrinology
Background:
- Pituitary adenomas are tumors that can affect the optic nerves.
- Compression of the visual pathway can lead to vision loss.
Purpose of the Study:
- To evaluate the utility of the contrast sensitivity function (CSF) as an indicator of visual pathway compression in patients with pituitary adenoma.
Main Methods:
- Assessed contrast sensitivity function in 40 patients diagnosed with pituitary adenoma.
Main Results:
- Contrast sensitivity function showed potential as an index for visual pathway compression in pituitary adenoma patients.
- However, the contrast sensitivity function demonstrated a lack of specificity for diagnosing this condition.
Conclusions:
- The contrast sensitivity function may serve as a supportive diagnostic tool for visual pathway compression in pituitary adenoma.
- Its limited specificity necessitates its use in conjunction with other diagnostic methods.